RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL

Recruiting Observational Study
Acute Lymphoblastic Leukemia, Adult
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 40
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Grupo Argentino de Tratamiento de la Leucemia Aguda · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a multicenter, observational real world clinical trial with prospective follow up that will evaluate the treatment outcome of adolescent and young patients with ph-negative acute lymphoblastic leukemia with first-line pediatric-like protocol in Argentina.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Signature of the form consent for participation in the study * Ph-negative ALL diagnosis without previous treatment. Exclusion Criteria: * ALL with mature B phenotype (sIg +) or with the cytogenetic alterations characteristic of ALL mature B (t (8,14), t (2, 8), t (8, 22)). …
Contacts

Luciana Ferrari, Dr.

541148771000

lferrari@fundaleu.org.ar

CONTACT

Paula Freigeiro

5491140470052

gatla.ar@gmail.com

CONTACT